About Stem Cell Technologies
Stem Cell Technologies is a company based in Vancouver (Canada) founded in 1993. Stem Cell Technologies has raised $11.92 million across 9 funding rounds from investors including National Research Council Canada, European Union and BDC. Stem Cell Technologies has completed 3 acquisitions, including Cellular Highways, Propagenix and SQZBiotech. Stem Cell Technologies offers products and services including Antibodies, Cell Culture Media, EasySep Kits, and CryoStor Media. Stem Cell Technologies operates in a competitive market with competitors including Abcam, Meridian Bioscience, Teknova, Sangon Biotech and Cayman Chem, among others.
- Headquarter Vancouver, Canada
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11.92 M (USD)
in 9 rounds
-
Latest Funding Round
$1.14 M (USD), Grant
Apr 01, 2021
-
Investors
National Research Council Canada
& 2 more
-
Employee Count
Not available
-
Investments & Acquisitions
Cellular Highways
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Stem Cell Technologies
Stem Cell Technologies offers a comprehensive portfolio of products and services, including Antibodies, Cell Culture Media, EasySep Kits, and CryoStor Media.
Products for detecting proteins in cell research applications
Media for growing and maintaining cells in laboratory settings
Kits for isolating specific cell types from samples
Solutions for cryopreserving cells effectively
People of Stem Cell Technologies
Unlock access to complete
Software Development Team
16 people
Senior Team
14 people
Finance and Accounting
13 people
Data Analysis and Operations Team
11 people
Product Management Team
7 people
Leadership Team
6 people
Sales and Marketing
4 people
Business Team
3 people
Unlock access to complete
Funding Insights of Stem Cell Technologies
Stem Cell Technologies has successfully raised a total of $11.92M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $1.14 million completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Stem Cell Technologies
Stem Cell Technologies has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include National Research Council Canada, European Union and BDC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Commercial banking services for small and medium-sized enterprises are provided.
|
Locked | Locked | Locked | |
|
Scientific and technological research is conducted for Canada's benefit.
|
Locked | Locked | Locked |
Investor details for Stem Cell Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Stem Cell Technologies
Stem Cell Technologies has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Cellular Highways, Propagenix and SQZBiotech.
Investment portfolio details for Stem Cell Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Microfluidic cell sorters are developed for research, diagnostics, and therapeutics.
|
Locked | Locked | 2016 | Locked | |
|
Cell models and therapies are developed using Conditional Replication technology.
|
Locked | Locked | 2014 | Locked | |
|
Cell therapies are developed using proprietary Cell Squeeze technology.
|
Locked | Locked | 2013 | Locked |
Complete acquisition details for Stem Cell Technologies
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Stem Cell Technologies
Detailed financials for Stem Cell Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Stem Cell Technologies Comparisons
Peer comparison for Stem Cell Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Stem Cell Technologies
Stem Cell Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Meridian Bioscience, Teknova, Sangon Biotech and Cayman Chem, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
Molecular diagnostic device and kits
|
|
| Locked | Locked | Locked |
Molecular biology reagents and kits are supplied for research applications.
|
|
| Locked | Locked | Locked |
Research services, reagents, and kits for biotech applications are provided.
|
|
| Locked | Locked | Locked |
Bioreagents and assay kits are developed, with preclinical services provided.
|
Detailed competitors of Stem Cell Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Stem Cell Technologies
Complete news archive for Stem Cell Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Stem Cell Technologies
Stem Cell Technologies was founded in 1993 and raised its 1st funding round 20 years after it was founded.
Stem Cell Technologies is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Stem Cell Technologies is a funded company, having raised a total of $11.92M across 9 funding rounds to date.
Stem Cell Technologies was founded in 1993 in Vancouver, Canada, within the life sciences sector. Cell culture media and ancillary reagents are produced to support research activities. Products designed for cell isolation, culturing, and assaying are offered, complemented by services and training programs. Operations focus on aiding scientists through these resources in a research-oriented environment.
Stem Cell Technologies's top competitors include Abcam, Meridian Bioscience and BBI Solutions.
Stem Cell Technologies offers Antibodies, Cell Culture Media, EasySep Kits, and CryoStor Media.
Stem Cell Technologies has made 3 acquisitions, including Cellular Highways, Propagenix, and SQZBiotech.
Stem Cell Technologies has 3 investors. Key investors include National Research Council Canada, European Union, and BDC.